DeepMed Research

Fluart Innovative Vaccine Ltd, Hungary

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Phase 1

Completed

Conditions: Human Influenza

Interventions: Biological: 4Fluart ID suspension for injection study drug 2 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted)
Biological: 3Fluart suspension for injection, influenza vaccine (whole virion, inactivated, adjuvanted)
Biological: 4Fluart ID suspension for injection study drug 1 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted)

First Posted Date: 2018-02-28

Last Posted Date: 2021-03-03

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 36

Registration Number: NCT03448705

Locations: 🇭🇺
Drug Research Center, Balatonfüred, Veszprém, Hungary

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Phase 3

Completed

Conditions: Human Influenza

Interventions: Biological: Vaccination with Fluval AB Novo suspension for injection, single intramuscular dose (0.5 ml)
Biological: Vaccination with Fluval AB Novo suspension for injection, half dose of a single intramuscular dose (0.25 ml)

First Posted Date: 2015-03-13

Last Posted Date: 2021-03-11

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 120

Registration Number: NCT02387294

Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection

Phase 4

Completed

Conditions: Influenza Prophylaxis

Interventions: Biological: Vaccination with Fluval AB suspension for injection

First Posted Date: 2013-05-29

Last Posted Date: 2021-04-05

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 120

Registration Number: NCT01863849

Locations: 🇭🇺
Family Doctor's Office, Budapest, Hungary
🇭🇺
District Doctor's Office, Szentendre, Hungary

Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

Phase 4

Completed

Conditions: Influenza

Interventions: Drug: Fluval AB vaccination

First Posted Date: 2012-07-25

Last Posted Date: 2012-10-12

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 120

Registration Number: NCT01649713

Locations: 🇭🇺
District Doctor's Office, Szentendre, Hungary

A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

Not Applicable

Completed

Conditions: Influenza

Interventions: Biological: Vaccination with FAB-6011
Biological: Vaccination with FluvalAB

First Posted Date: 2011-10-25

Last Posted Date: 2012-05-21

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 1206

Registration Number: NCT01459276

Locations: 🇭🇺
Family Doctor's Office, Pilisvörösvár, Hungary
🇭🇺
Péter Vajer, Biatorbágy, Pest, Hungary
🇭🇺
Barna Bőze, Hatvan, Pest, Hungary

and more 1 locations

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Not Applicable

Completed

Conditions: Influenza

Interventions: Biological: Vaccination with FAB-6011
Biological: Vaccination with FAB-9011
Biological: Vaccination with FluvalAB
Biological: Vaccination with FAB-3511

First Posted Date: 2011-08-03

Last Posted Date: 2012-05-21

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 256

Registration Number: NCT01408290

Locations: 🇭🇺
Family Doctor's Office, Budapest, Hungary

Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

Not Applicable

Completed

Conditions: Novel 2009 Influenza H1N1
Influenza, Human

Interventions: Biological: Vaccination with Fluval AB Novo
Biological: Vaccination with Fluval AB
Biological: Vaccination with Fluval P monovalent influenza vaccine

First Posted Date: 2011-08-02

Last Posted Date: 2012-05-21

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 58

Registration Number: NCT01407978

Locations: 🇭🇺
"Csolnoky Ferenc" Veszprém County Hospital, Veszprém, Hungary

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Vaccination with Fluval AB influenza vaccine

First Posted Date: 2011-07-27

Last Posted Date: 2012-05-21

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 121

Registration Number: NCT01404182

Locations: 🇭🇺
Family Doctor's Office, Pilisvorosvar, Pest, Hungary
🇭🇺
Fourmed Gyogyhaz Kft., Veszprem, Hungary

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

Not Applicable

Completed

Conditions: Influenza

Interventions: Biological: Vaccination with FLUVAL P

First Posted Date: 2010-04-08

Last Posted Date: 2012-05-21

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 10

Registration Number: NCT01100294

Locations: 🇭🇺
"Csolnoky Ferenc" Veszprém County Hospital, Veszprém, Hungary

Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine

Not Applicable

Completed

Conditions: Influenza

Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine
Biological: Vaccination with Fluval P and Fluval AB influenza vaccines

First Posted Date: 2009-11-10

Last Posted Date: 2012-05-21

Lead Sponsor: Fluart Innovative Vaccine Ltd, Hungary

Target Recruit Count: 355

Registration Number: NCT01010893

Locations: 🇭🇺
District Doctor's Office, Pilisvorosvar, Hungary
🇭🇺
Fourmed Kft. Gyogyhaz, Veszprem, Hungary

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy